Hospira, Inc. ("Hospira") is a provider of injectable pharmaceutical drugs and
infusion technologies that it develops, manufactures, distributes and markets
globally. Through a broad, integrated product portfolio, Hospira is uniquely
positioned to Advance Wellness� by improving patient and caregiver safety while
reducing healthcare costs. Hospira's portfolio includes generic acute-care and
oncology injectables, biosimilars, and integrated infusion therapy and
medication management products. Hospira's broad portfolio of products is used by
hospitals and alternate site providers, such as clinics, home healthcare
providers and long-term care facilities.
Hospira was incorporated in Delaware on September 16, 2003, as a wholly owned
subsidiary of Abbott Laboratories ("Abbott"). Hospira's business first began
operation as part of Abbott in the 1930s.